+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Area Market Research Reports

Ovarian Cancer Pricing, Reimbursement, and Access - Product Thumbnail Image

Ovarian Cancer Pricing, Reimbursement, and Access

  • Report
  • March 2018
  • 159 Pages
  • Global
From
Asthma Forecast and Market Analysis to 2024 - Product Thumbnail Image

Asthma Forecast and Market Analysis to 2024

  • Report
  • February 2018
  • 680 Pages
  • Global
From
The Ins-and-Outs of Critical Care Billing - Product Thumbnail Image

The Ins-and-Outs of Critical Care Billing

  • Training
  • 60 Minutes
  • Global
Bloodborne Pathogens - Product Thumbnail Image

Bloodborne Pathogens

  • Training
  • 60 Minutes
  • Global
From
Cardiology Mid-Year Coding Update 2017 - Product Thumbnail Image

Cardiology Mid-Year Coding Update 2017

  • Training
  • 60 Minutes
  • Global
Life Safety Code - ESRD - Product Thumbnail Image

Life Safety Code - ESRD

  • Training
  • 60 Minutes
  • Global
Allergen Awareness and Control in Food Processing - Product Thumbnail Image

Allergen Awareness and Control in Food Processing

  • Training
  • 60 Minutes
  • Global
Loading Indicator

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs. Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more